Announcement

iKure Techsoft Private Limited announced that it has closed a USD 1.8 million Pre‑Series A financing round. The round was led by four independent investors – Philips Foundation, World Diabetes Foundation, Bayer Foundation (invested through the We Share Forward platform) and Prourgn LLC of Japan – each of which made an independent decision to invest after evaluating iKure’s delivery model, technology platform and scalability.

Company Overview

iKure operates across eleven Indian states, reaching more than 7,900 villages and serving a population of over 36 million people. To date the company has recorded more than 4.5 million patient interactions. Its service network comprises over 400 trained Community Health Activists, more than 10,000 women‑led Self‑Help Groups, and a suite of primary‑care hubs, clinics, pharmacies, diagnostics centres and tele‑medicine services. All services are integrated through WHIMS, iKure’s proprietary digital health platform that maintains longitudinal patient records.

Funding Details

The USD 1.8 million proceeds will be deployed to:

  • Increase the number of Community Health Activists and expand the footprint of primary‑care hubs, clinics, pharmacies and diagnostic facilities in underserved regions.
  • Strengthen the WHIMS platform, including the development of AI‑enabled clinical decision‑support tools that provide early risk warnings to field workers and enhance the capacity of clinical teams to manage larger patient cohorts.
  • Implement remote patient‑monitoring capabilities and further workforce‑development programmes, both of which reinforce iKure’s model of continuous, community‑based care.

The investment is earmarked for scaling existing operations rather than launching new lines of business.

Quotes

  • Sujay Santra, Founder and CEO, iKure: “Every part of this investment is intended to ensure that patients remain connected to care long after their first consultation, whether that means training more health workers or sharpening what our technology can flag before a condition worsens.”
  • Bahaa Eddine Sarroukh, Director & Head, Philips Foundation Impact Investments: “Improving access to quality healthcare for underserved communities is at the heart of Philips Foundation’s mission. We invested in iKure because its model combines trusted community health networks, primary care and digital tools to keep people connected to care beyond the first consultation.”
  • Cansu Unalan, Project Manager, World Diabetes Foundation: “Strong primary healthcare systems are essential to improving prevention, early detection and management of diabetes and other chronic diseases. iKure’s community‑health‑activist‑driven, technology‑enabled approach aligns with our ambition to reach underserved communities at scale.”
  • Rieko Yano, Founder and CEO, Prourgn LLC: “The hardest part is the last mile. iKure has built trusted health workers, community clinics and the follow‑through that makes technology actually work in a village.”
  • Mariano Larena, Managing Director, We Share Forward: “Mobilising this kind of collective, high‑caliber philanthropic capital is exactly the impact we exist to create. Beyond the funding itself, we are inspired by what it will help iKure achieve: strengthening its frontline health‑worker network and expanding access to diabetes and non‑communicable disease care for more underserved communities across India.”
  • Stefan Wilhelm, Director, Social Innovation & Head LATAM & Africa, Bayer Foundation: “Health equity starts in communities. Through trusted local health workers and accessible primary care, iKure is expanding quality healthcare for underserved populations.”

Outlook

The Pre‑Series A round positions iKure to deepen its engagement with state health systems and national health planning, moving from strong regional coverage toward broader state‑level integration. While the model is designed for potential replication beyond India, the immediate focus remains on scaling the existing healthcare infrastructure across the country.